Skip to main content

Table 5 Analysis of p53 expression in node-negative and node-positve cases and in the 31 cases with lymphnodal involvment (N1 vs N2)

From: Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer

 

p53 positive

p53 negative

Node negative

42 (45%)

21 (22%)

Node positive

28 (30%)

3 (3%)

pT1-3N1

13 (42%)

2 (6%)

pT1-3N2

15 (48%)

1 (3%)